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ABSTRACT
Hypertrophic cardiomyopathy is a complex cardiac disease with unique pathophysiologic characteristics and a great diversity of 
morphologic, functional, and clinical features. It is characterized by a massive asymmetrical hypertrophy of the myocardium. Clinical 
features range from an absence of symptoms to sudden death. We report a rare case of a 57-year-old male presenting with a history of 
constipation for 3 months, weight loss and fatigue for 3 months, and blood in stools for 1 month. He was diagnosed with a carcinoma 
rectum. He was planned for abdominoperineal resection by laparoscopic approach. Aim of this case report is to discuss the challenging 
technical nuances of anesthetic management of a patient with hypertrophic cardiomyopathy posted for laparoscopic surgery.
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Hypertrophic cardiomyopathy (HCM) is a complex cardiac disease with unique pathophysiologic characteristics. This relatively common heart disease 
has a great diversity of morphologic, functional and clinical 
features. It has an incidence of 1 in 500 [1]. It is an autosomal 
dominant condition and is the most common genetic cardiac 
disease [1]. It is characterized most commonly by the left 
ventricular hypertrophy with heart failure and sudden cardiac 
death. Physiologically, the systolic murmur of HCM is 
characteristically aggravated my decreasing the venous return 
to heart, which is usually done by asking the patient to stand 
up from the supine position or do the Valsalva maneuver [2]. 
Around 20% of HCM patients develop atrial fibrillation (AF), 
which exacerbates other accompanying clinical symptoms and 
carries a risk of embolic stroke [2].
These patients can experience anginal chest pain due 
to ischemia from a (blood) supply and demand (excess 
myocardium) mismatch [3]. HCM poses unique challenges for 
conducting an anesthetic intervention. In this report, we highlight 
the preoperative assessment, intraoperative and postoperative 
management of anesthesia in HCM patients providing and 
reviewing many learning points regarding its management.
CASE REPORT
A 57-year-old male patient presented with the diagnosis of 
carcinoma rectum posted for laparoscopic abdominoperineal 
resection. On preoperative evaluation day before surgery, 
the patient had no significant history except a history of 
hemorrhoidectomy 23 years back under spinal anesthesia, which 
was uneventful. He had undergone 27 cycles of radiotherapy 
for carcinoma and the last cycle was one year back. He had no 
other co-morbidity. On examination, pulse rate was 77/min and 
blood pressure was 112/70 mmHg. The respiratory rate was 16/
min. Clinically, the airway and all other systemic examinations 
were normal.
Routine blood investigations and chest X-ray were grossly 
within normal limits (Fig. 1). Electrocardiogram (ECG) showed 
ST depression with significant T wave inversion in anterolateral 
chest leads (Fig. 2). Two-dimensional echocardiography showed 
asymmetrical septal hypertrophy, features suggestive of HCM 
(non-obstructive), grade 2 left ventricle diastolic dysfunction, 
mild mitral regurgitation (MR) and normal left ventricle ejection 
fraction (LVEF 60%). Due to HCM, invasive monitoring was 
Figure 1: Chest X-ray of the patient at the end of inspiration.
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planned during surgery. The patient was kept nil per oral for eight 
hours before surgery. Tablet alprazolam 0.25mg was given at 
night and 6am on the day of surgery with a sip of water. Written, 
informed, and explained consent was obtained from the patient 
and his family.
On the day of surgery, the patient was shifted to the operation 
theatre. Monitors attached and vitals were recorded. Peripheral 
venous access was secured by using an 18G intravenous (I/V) 
cannula on the left forearm. Under all aseptic conditions, the 
epidural catheter was inserted at L1- L2 space and fixed at 
10cm from the skin. The patient was sedated with injection 
midazolam (0.05mg/kg) and injection morphine (0.1 mg/kg). An 
arterial catheter was placed in the right radial artery under local 
anesthesia. The right-sided internal jugular vein was cannulated, 
and the central venous pressure (CVP) monitor was attached.
After premedication with injection glycopyrrolate (0.005mg/
kg) and injection ondansetron (0.1 mg/kg), preoxygenation with 
100% oxygen was done for 3 minutes. Induction was done with 
injection propofol (1mg/kg) given slowly in incremental doses 
and injection vecuronium (0.08 mg/kg). Injection esmolol (0.5 
mg/kg) was administered to attenuate the laryngoscopic response. 
The patient was intubated with an 8mm ID endotracheal tube.
Anesthesia was maintained using 50% nitrous oxide in oxygen, 
isoflurane (0.8-1%) and injection vecuronium boluses. The 
ventilator was adjusted to achieve Spo2>95% and end-tidal CO2 
of 33-36 mmHg through tidal volumes of 6ml/kg, frequency 
of 10-14/min and I:E ratio 1:2. The patient was placed in the 
lithotomy position. Carbon dioxide insufflation was done slowly 
at the start of the surgery for creation of pneumoperitoneum to 
allow visualization of intraabdominal organs. The intraabdominal 
pressure was kept below 15 mmHg.Epidural top-up administered 
1 hour after the start of surgery, and after every 1 hour, 6 ml of 
0.25% ropivacaine administered.
The procedure lasted for 6.5 hours during which the patient 
remained hemodynamically stable except there were two episodes 
of hypotension which responded to 200ml bolus of normal 
saline and 100 microgram phenylephrine. CVP guided fluid 
was administered and CVP was kept between 12-13 cm H2O. 
Urine output was measured at regular intervals throughout the 
surgery. Intraoperative ECG showed ST depression and inverted 
T waves, but sinus rhythm was maintained throughout. At the 
end of the surgery, neuromuscular blockade was reversed with 
injection glycopyrrolate (0.008mg/kg), and injection neostigmine 
(0.05mg/kg) and the patient was extubated.
The patient was shifted and monitored in the Intensive Care 
Unit (ICU) during the postoperative period. Regular monitoring 
of heart rate, blood pressure, urine output, CVP, and temperature 
were done. Epidural analgesia was continued in the postoperative 
period for 48 hrs. All other factors like pain, shivering, anxiety, 
hypoxia, and hypercarbia, which can stimulate sympathetic 
activity were monitored and taken care accordingly. The patient 
did well after the surgery. On the last follow-up at 6 months, he 
was doing fine.
DISCUSSION
Hypertrophic cardiomyopathy is the most common genetic 
cardiovascular disease caused by a multitude of mutations in 
genes encoding proteins of the cardiac sarcomere [4]. This case 
highlights many important physiological aspects with which an 
anesthesiologist must be versed so as to manage this condition 
effectively. As described earlier, decreasing the preload not only 
increases the murmur of HCM, but it also increases the sub-aortic 
stenosis leading to decreased stroke volume. So, an adequate 
CVP guided fluid is required to ensure adequate stroke volume 
and hence cardiac output in this condition [5].
Anesthetic implications of management of a case of HCM for 
non-cardiac surgery, therefore, include intensive cardiovascular 
monitoring and management of perioperative complications 
[6]. This can be achieved by maintaining adequate preload 
and afterload; avoiding vasodilators and agents that increase 
contractility [7]. Preloading before induction helps maintain 
stroke volume and minimizes adverse events of positive pressure 
ventilation. Premedication with midazolam helps in alleviating 
anxiety thus avoiding unnecessary sympathetic stimulation. In 
our patient, smooth induction with injection propofol and prior 
esmolol administration to blunt sympathetic response during 
intubation was done. Propofol is generally avoided in cardiac 
induction due to its cardio-depressant effect; however in HCM, 
we need mild cardiac depression, so propofol was used [6]. 
Preload reduction and severe hypotension may be encountered 
during the creation of pneumoperitoneum for laparoscopic 
surgery. Therefore, in our case, the surgeon was advised to 
insufflate the abdomen slowly and at a pressure not exceeding 
15mmHg [8].
We maintained CVP at 12-13cm of H2O, thus maintaining 
adequate preload to maintain optimal cardiac output. We 
inserted an epidural catheter for intraoperative analgesia and 
post-operative pain relief. Sahoo RK et al. [9], Ahmed A et 
al.[10] did similar studies but in contrast to their studies, our 
study was unique in that ours is the first study reporting the 
successful use of anesthesia along with laparoscopic technique 
in HCM patients. 
Figure 2: Electrocardiogram (ECG) showing ST depression with 
significant T wave inversion in anterolateral chest leads.
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CONCLUSION
Management of hypertrophic cardiomyopathy includes a thorough 
understanding of the pathophysiology of the condition and 
maintaining specific hemodynamic goals to prevent perioperative 
complications associated with it.
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